Novel tool compounds for exploring the Delta receptors as neurotherapeutic targets

Professor

University of Copenhagen

Professor Lennart Bunch’s project aims to make available to the scientific community the first selective tool compounds for studies of the physiological role of GluD1 and GluD2 and their potential as novel therapeutic targets.

He has received a Lundbeck Foundation Ascending Investigator research grant of DKK 4.999.025.